Do You Need a License to Sell Peptides in Louisiana?

There is no single document called a "peptide license." Selling research peptides in Louisiana generally breaks into three separate questions: whether your business entity is properly formed and registered, whether the products you carry and the way you distribute them pull you into drug or wholesale-distributor licensing, and whether your operation genuinely stays inside the research-use-only lane in both substance and marketing. Which of those apply to you depends on your entity, your catalog, your customer base, and your claims. Only a Louisiana-licensed attorney and the relevant state boards can answer them for your specific setup. This page is informational and is not legal advice.

Three questions compressed into one

Most operators asking about licensing are actually asking three unrelated things at once, and they have three different answerers. Separating them is the single most useful thing you can do before you spend money on counsel, because it turns a vague worry into a short list of specific filings and questions.

The first layer is the least ambiguous and the one people skip least often. The second is where the genuine uncertainty lives, and it is fact-specific: what a business sells, who it sells to, whether it holds inventory, whether it repackages, and whether the compound is a regulated drug all matter. Nobody should tell you in a blog post that a given activity is permitted or prohibited in your state. What you can do is walk in with the right questions.

The third layer is the one operators most often underestimate, because it is not resolved by a filing. You do not get a certificate that says you are research-use-only. It is a posture you demonstrate through your product labeling, your site copy, your ad accounts, your customer onboarding, and your refusal to answer certain questions. It can be undone by a single sentence written by a marketing contractor who did not know the rules.

What research-use-only actually constrains

Research-use-only is not a disclaimer you paste in a footer. It is a description of what the product is and what your business does with it. Compounds sold on that basis are not FDA-approved drugs, are not supplied for human consumption, and are not accompanied by dosing, administration, or protocol guidance. A supplier operating properly will not give you that guidance either, and a supplier that volunteers it is telling you something about its own risk tolerance that should concern you.

Practically, this shapes several parts of your operation. Your product pages describe the compound and what research suggests about its mechanism, hedged honestly, rather than promising an outcome. Your labels carry research-use language and lot identifiers rather than instructions. Your staff training covers what questions they cannot answer. Your marketing does not use before-and-after imagery, testimonials describing personal results, or language borrowed from the clinical world.

This is also why the way you describe your own business matters. Adding research peptides to a catalog is a sourcing and inventory decision. Anything that describes administering a compound to a person is a different activity entirely, governed by a different body of rules, and it is your counsel's job — not your supplier's — to tell you where your operation sits. A wholesale supplier's role ends at supplying a documented, tested product to a verified business.

The questions to write down before you call counsel

Counsel time is expensive and the quality of the answer tracks the quality of the question. Before that conversation, assemble the following, because each one changes the analysis:

What exactly is in your intended catalog, compound by compound, with the supplier's documentation attached. Whether you will hold physical inventory, ship from your own location, or route orders elsewhere. Whether you will repackage, relabel, or alter anything, which is a materially different activity from reselling sealed units. Who your buyers are and how you verify them. Whether any part of your business also involves licensed practitioners, because that connection can pull otherwise separate regulatory regimes together. And what your marketing actually says today, printed out, not from memory.

Then ask counsel and your state board the specific questions: does this activity, with this catalog, in this configuration, require registration as a distributor of any kind; what recordkeeping obligations attach; what labeling obligations attach; and what would change the answer. Ask what would need to be true for the answer to flip, because that tells you which growth moves are safe and which ones require a second review.

Do not accept a general answer for a specific business, and do not accept a specific answer from anyone who has not seen your documents. Rules in this area are read against facts, and the facts are yours.

How a wholesale account actually gets qualified

On the supply side, the mechanics are more predictable. A legitimate research peptide supplier does not sell wholesale to anyone with a credit card. It qualifies the buyer, and that qualification is itself part of the compliance posture on both sides of the transaction.

Expect to provide your legal entity name, business registration details, the type of operation you run, and a plain statement of what you intend to do with the products. Expect the supplier to decline accounts that do not fit, and treat a supplier that never asks as a warning rather than a convenience. The friction is the point: a supplier that verifies buyers is a supplier that is building records, and records are what protect a business when questions arrive later.

Pricing mechanics vary by supplier and category, and anyone quoting you a universal margin figure is guessing. What is consistent is the structure: wholesale pricing is generally tiered by volume, with minimum order quantities that differ by compound because manufacturing cost and demand differ by compound. Margins vary widely with volume, category, and how you position your own catalog. Any supplier promising a specific return is making a claim it cannot support, and you should discount everything else it says accordingly.

What you should insist on seeing before you commit is the pricing itself. A program that will not show tiers until you have submitted an application, sat through a call, and given up your contact details is optimizing for its sales process rather than your decision.

What separates a supplier you can defend from one you can't

If a regulator, an insurer, or a serious buyer asks where your inventory came from, the answer needs to be documentable. That is the standard to shop against, and it narrows the field quickly.

Start with the certificate of analysis. A usable COA carries a lot or batch number that matches the vial in your hand, identifies the testing method, and includes the actual chromatogram rather than a summary line. Verify that you can pull the document yourself without asking a salesperson for it. Several practices common in this industry should end a conversation: COAs sold as an add-on, "certificates" with no lot identifier, testing claimed in marketing copy with no document behind it, and results that cannot be traced to a named laboratory.

Then look at purity and the panels behind it. High-performance liquid chromatography establishes purity. Identity confirmation, sterility, and contaminant panels establish the rest. Ask which panels run on every batch versus which run occasionally, because "tested" without specifics is not information.

Finally, look at fulfillment and catalog behavior. Domestic fulfillment is not just a speed question — it determines whether your inventory sits in transit through customs at a time you cannot control. And watch how the supplier markets. A catalog that drifts into human-use framing, or that leans on compounds positioned in clinical language, tells you how that supplier will handle your account when something goes wrong.

What Real Peptides does differently

Real Peptides supplies research-use-only compounds to businesses through its Wholesale Partner Program, and the program is built around the verification points above rather than around a sales call.

Every compound is manufactured to 99%+ HPLC purity, and each batch runs through a multi-panel testing process. The resulting certificates of analysis are publicly verifiable — the reader can check the lab results directly, matched to batch, without opening an account, submitting a form, or paying for the document. That is a deliberate inversion of the industry norm where documentation is treated as a sales asset rather than a product requirement.

Fulfillment is US-based rather than routed through overseas transshipment, and current shipping windows are published on the program page rather than promised on a call. The catalog spans research categories from foundational compounds through the broader popular peptides collection, so a buyer building a shelf can source consistently from one documented supply chain instead of assembling one from three vendors with three different testing standards.

The application itself is three steps: submit your business details, get verified, and receive tier pricing. Real Peptides does not supply compounds framed for human use, does not provide dosing or protocol guidance, and does not advise on whether your business model is permissible where you operate — that is your attorney's work, and any supplier telling you otherwise is overstepping.

Where this leaves a serious buyer

If your entity is registered, your counsel has reviewed your catalog and your marketing, and your remaining question is sourcing, the supplier decision comes down to documentation you can verify and pricing you can see before you commit. That is the standard worth holding, whether or not Real Peptides is the supplier you land on.

Qualified businesses can review program terms and tier structure through the wholesale peptides program, apply for a wholesale account once your entity details are ready, or read the broader background on do you need a license to sell peptides before you take the licensing question to counsel.